US Stock MarketDetailed Quotes
NVIVQ INVIVO THERAPEUTICS HOLDING CORP
- 0.370
- 0.0000.00%
15min DelayClose Jul 15 16:00 ET
1.15MMarket Cap-0.11P/E (TTM)
0.000High0.000Low0Volume0.000Open0.370Pre Close0.00Turnover0.00%Turnover RatioLossP/E (Static)3.11MShares1.05052wk High0.13P/B1.03MFloat Cap0.15052wk Low--Dividend TTM2.77MShs Float465000.000Historical High--Div YieldTTM0.00%Amplitude0.150Historical Low--Avg Price1Lot Size
About INVIVO THERAPEUTICS HOLDING CORP Company
InVivo Therapeutics Holdings Corp is a research and clinical stage biomaterials and biotechnology company. It focuses on the treatment of spinal cord injury. The company's product pipeline consists of Neuro spinal scaffold and Bioengineered neural trails. The firm has a clinical development program for acute spinal cord injury and a preclinical development program for chronic spinal cord injury.
Company Profile
SymbolNVIVQ
Company NameINVIVO THERAPEUTICS HOLDING CORP
CEODr. Richard M. Toselli, M.D.
MarketPink Market
Employees6
Fiscal Year Ends12-31
Company Executives
- Name
- Position
- Salary
- Dr. Richard M. Toselli, M.D.
- Director, President and Chief Executive Officer
- 960.00K
- Richard C. Christopher
- Treasurer, Chief Financial Officer and Principal Accounting Officer
- 583.78K
- Heather Hamel
- Chief Legal Officer and General Counsel
- 476.57K
- C. Ann Merrifield
- Non-Executive Chairman of the Board
- 87.38K
- Christina T. Morrison
- Independent Director
- 66.76K
- Dr. Robert J. Rosenthal, PhD
- Independent Director
- 68.01K
- Dr. Richard J. Roberts, PhD
- Independent Director
- 58.01K
Heat List
US
Overall
Symbol
Price
% Chg
No Data